Sanjar Pharma LLP, a renowned name in injectable pharmaceutical manufacturing, proudly participated in the prestigious IPHEX International Exhibition for Pharma and Healthcare held from August 28th to 30th, 2024 at IEML Knowledge Park-2, Greater Noida Expressway, Delhi NCR, India. The event brought together leading pharmaceutical manufacturers, healthcare institutions, and global buyers under one roof, offering an excellent platform to exhibit cutting-edge pharmaceutical solutions.
Sanjar Pharma Founded in 2014 and headquartered in Gujarat, India. Sanjar Pharma LLP holds WHO-GMP, GLP, and ISO certifications, and has earned a reputation for delivering safe, reliable, and affordable injectable products. During the exhibition, we presented our diverse product range, including Liquid Vials, Ampoule Injections, Pre-Filled Syringes (PFS), Eye/Ear Drops, and Dry Powder Injections, all manufactured under strict quality standards.
Showcasing Global Strength
Sanjar Pharma’s presence at IPHEX 2024 emphasized our growing global footprint. We proudly hold pharmaceutical manufacturing and export licenses in multiple countries including Uganda, Yemen, Nepal, Namibia, and the Philippines, among others. Our regulatory approvals across these regions reflect our commitment to delivering high-quality medicines that meet international standards.
Highlights from the Exhibition
At the IPHEX Exhibition, Sanjar Pharma showcased an extensive portfolio that includes products across therapeutic categories such as:
- Antibacterials
- Antimalarials
- Antiemetics
- CNS Drugs
- Glutathione Injections
- Ampoules, Vials, and Dry Powder Injections
The event proved to be a remarkable success, with tremendous interest shown by industry professionals, healthcare buyers, distributors, and international delegates. It served as a valuable opportunity to highlight our advanced manufacturing capabilities and explore strategic collaborations with industry stakeholders.
A Step Forward in Healthcare Collaboration
Participation in IPHEX 2024 marks yet another significant milestone in our journey to contribute to global healthcare. The enthusiastic response and productive interactions have further strengthened Sanjar Pharma’s position as a trusted pharmaceutical partner. We remain committed to innovation, quality, and expanding access to affordable healthcare worldwide.
Sanjar Pharma LLP extends heartfelt thanks to all visitors, partners, and industry professionals who connected with us at the exhibition. We look forward to building on the momentum created at IPHEX and continuing to deliver pharmaceutical excellence across borders.
